相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Managing Lung Cancer with Comorbid Interstitial Pneumonia
Eiki Ichihara et al.
INTERNAL MEDICINE (2020)
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
Eniko Barczi et al.
THORACIC CANCER (2020)
Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment
Norimitsu Kasahara et al.
THORACIC CANCER (2020)
High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery
Shun Takao et al.
MEDICINE (2019)
Serum prealbumin is a prognostic indicator in idiopathic pulmonary fibrosis
Biyun Li et al.
CLINICAL RESPIRATORY JOURNAL (2019)
Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Yoshimasa Hachisu et al.
MEDICINA-LITHUANIA (2019)
Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer
Shohei Hamada et al.
BMC PULMONARY MEDICINE (2019)
Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage
Myung Jin Song et al.
JOURNAL OF ONCOLOGY (2019)
Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer
Satoshi Nakao et al.
ANTICANCER RESEARCH (2019)
Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation
Nobuyuki Koyama et al.
PLOS ONE (2019)
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia
Takashi Ogura et al.
RESPIRATORY INVESTIGATION (2019)
Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients
Ting Zhou et al.
JOURNAL OF CANCER (2019)
Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute
Kei Sonehara et al.
CHEMOTHERAPY (2019)
Postoperative acute exacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study
Takuto Miyamura et al.
RESPIRATORY RESEARCH (2019)
Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis
Hye S. Kang et al.
RESPIROLOGY (2018)
Lung cancer and interstitial lung disease: a literature review
Jean-Marc Naccache et al.
JOURNAL OF THORACIC DISEASE (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Pretherapeutic Inflammation Predicts Febrile Neutropenia and Reduced Progression-Free Survival after First-Line Chemotherapy in SCLC
Diego Kauffmann-Guerrero et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer
Haruki Kobayashi et al.
RESPIROLOGY (2017)
Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis
Jing Jin et al.
PLOS ONE (2017)
Modified glasgow prognostic score in patients with small-cell lung cancer
Koichi Kurishima et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis
Keiji Oishi et al.
INTERNAL MEDICINE (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer
Yasunori Enomoto et al.
LUNG CANCER (2016)
Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia
Takahiro Omori et al.
ANNALS OF THORACIC SURGERY (2015)
Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease
Yasunori Enomoto et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
Hirotsugu Kenmotsu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Kensuke Kataoka et al.
CHEST (2015)
Prognosis in advanced lung cancer - A prospective study examining key clinicopathological factors
Claribel P. Simmons et al.
LUNG CANCER (2015)
Radiological Characteristics, Histological Features and Clinical Outcomes of Lung Cancer Patients with Coexistent Idiopathic Pulmonary Fibrosis
K. A. Khan et al.
LUNG (2015)
A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer
Ting Zhou et al.
TUMOR BIOLOGY (2015)
Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis
Naohiro Watanabe et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer
Toshihiko Sato et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival
Taehoon Lee et al.
RESPIRATORY MEDICINE (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Prognostic Significance of Preexisting Interstitial Lung Disease in Japanese Patients With Small-Cell Lung Cancer
Yosuke Togashi et al.
CLINICAL LUNG CANCER (2012)
The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer
Ioannis Gioulbasanis et al.
LUNG CANCER (2012)
Clinical characteristics of patients with lung cancer and idiopathic pulmonary fibrosis in China
Yan Xu et al.
THORACIC CANCER (2012)
Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis
Kyung Jong Lee et al.
THORACIC CANCER (2012)
Prognostic and predictive factors for lung cancer
Marianne Paesmans
BREATHE (2012)
Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis
Yuichi Saito et al.
ANNALS OF THORACIC SURGERY (2011)
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
J. W. Song et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
The Feasibility Study of Carboplatin Plus Etoposide for Advanced Small Cell Lung Cancer with Idiopathic Interstitial Pneumonias
Yuji Minegishi et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Serum Albumin Concentration and Waiting List Mortality in Idiopathic Interstitial Pneumonia
David A. Zismam et al.
CHEST (2009)
Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer Therapy
Yuji Minegishi et al.
INTERNAL MEDICINE (2009)
Cumulative incidence of and predictive factors for lung cancer in IPF
Yuichi Ozawa et al.
RESPIROLOGY (2009)
Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study
Shoji Kudoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?
Atsushi Watanabe et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK
Ivan Le Jeune et al.
RESPIRATORY MEDICINE (2007)
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
H. Okamoto et al.
BRITISH JOURNAL OF CANCER (2007)
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2004)
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2003)
A clinical study of idiopathic pulmonary fibrosis based on autopsy studies in elderly patients
T Araki et al.
INTERNAL MEDICINE (2003)
Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis
MC Aubry et al.
MAYO CLINIC PROCEEDINGS (2002)
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
W Noda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Lung cancer in patients with idiopathic pulmonary fibrosis
J Park et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Lung cancer and cryptogenic fibrosing alveolitis - A population-based cohort study
R Hubbard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
